Regulation of telomerase by human papillomaviruses

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 70, Issue , 2005, Pages 209-215

  Galloway, D A ^a   Gewin, L C ^a,c   Myers, H ^a,d   Luo, W ^a,e   Grandori, C ^a   Katzenellenbogen, R A ^a,b   McDougall, J K ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; PROTEIN E6; PROTEIN NUCLEAR FACTOR BINDS TO X1 BOX; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SIN3A; UNCLASSIFIED DRUG;

ACETYLATION; CONFERENCE PAPER; E BOX ELEMENT; ENZYME ACTIVITY; ENZYME REGULATION; EPITHELIUM CELL; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; WART VIRUS; ARTICLE; DNA TRANSCRIPTION; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE INACTIVATION; HUMAN; PAPILLOMAVIRIDAE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VIRUS CARCINOGENESIS; WESTERN BLOTTING;

BINDING SITES; DNA-BINDING PROTEINS; EPITHELIAL CELLS; FEMALE; HUMANS; MODELS, BIOLOGICAL; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; TELOMERASE; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

PAPILLOMAVIRIDAE;

EID: 33746404135     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2005.70.041     Document Type: Conference Paper

References (43)

1. Benanti J.A. and Galloway D.A. 2004. Normal human fibroblasts are resistant to RAS-induced senescence. Mol. Cell. Biol. 24: 2842.
2. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., and Wright W.E. 1998. Extension of life-span by introduction of telomerase into normal human cells (comment). Science 279: 349.
3. Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., and the W.H.O. International Agency for Research on Cancer. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol. 6: 204.
4. Demers G.W., Foster S.A., Halbert C.L., and Galloway D.A. 1994. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. 91: 4382.
5. Ducrest A.L., Amacker M., Mathieu Y.D., Cuthbert A.P., Trott D.A., Newbold R.F., Nabholz M., and Lingner J. 2001. Regulation of human telomerase activity: Repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity. Cancer Res. 61: 7594.
6. Gewin L. and Galloway D.A. 2001. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J. Virol. 75: 7198.
7. Gewin L., Myers H., Kiyono T., and Galloway D.A. 2004. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev. 18: 2269.
8. Greenberg R.A., O'Hagan R.C., Deng H., Xiao Q., Hann S.R., Adams R.R., Lichtsteiner S., Chin L., Morin G.B., and DePinho R.A. 1999. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18: 1219.
9. Gross-Mesilaty S., Reinstein E., Bercovich B., Tobias K.E., Schwartz A.L., Kahana C., and Ciechanover A. 1998. Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc. Natl. Acad. Sci. 5: 8058.
10. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., and Weinberg R.A. 1999. Creation of human tumour cells with defined genetic elements (comment). Nature 400: 464.
11. Helt A.M. and Galloway D.A. 2001. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J. Virol. 75: 6737.
12. Horikawa I. and Barrett J.C. 2003. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 24: 1167.
13. Horikawa I., Oshimura M., and Barrett J.C. 1998. Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol. Carcinog. 22: 65.
14. Hou M., Wang X., Popov N., Zhang A., Zhao X., Zhou R., Zetterberg A., Bjorkholm M., Henriksson M., Gruber A., and Xu D. 2002. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells. Exp. Cell Res. 274: 25.
15. Howley P.M. and Schlegel R. 1988. The human papillomaviruses: An overview. Am. J. Med. 85: 155.
16. Huibregtse J.M., Scheffner M., and Howley P.M. 1993. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13: 4918.
17. Kessis T.D., Slebos R.J., Nelson W.G., Kastan M.B., Plunkett B.S., Han S.M., Lorincz A.T., Hedrick L., and Cho K.R. 1993. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. 90: 3988.
18. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L.C., Coviello G.M., Wright W.E., Weinrich S.L., and Shay J.W. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011.
19. Kinoshita T., Shirasawa H., Shino Y., Moriya H., Desbarats L., Eilers M., and Simizu B. 1997. Transactivation of prothymosin α and c-myc promoters by human papillomavirus type 16 E6 protein. Virology 232: 53.
20. Kiyono T., Foster S.A., Koop J.I., McDougall J.K., Galloway D.A., and Klingelhutz A.J. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells (comment). Nature 396: 84.
21. Klingelhutz A.J., Foster S.A., and McDougall J.K. 1996. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380: 79.
22. Klingelhutz A.J., Barber S.A., Smith P.P., Dyer K., and Mc-Dougall J.K. 1994. Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol. Cell. Biol. 14: 961.
23. Kuhn U. and Wahle E. 2004. Structure and function of poly(A) binding proteins. Biochim. Biophys. Acta 1678: 67.
24. Lin S.Y. and Elledge S.J. 2003. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113: 881.
25. Lindvall C., Hou M., Komurasaki T., Zheng C., Henriksson M., Sedivy J.M., Bjorkholm M., Teh B.T., Nordenskjold M., and Xu D. 2003. Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: Activation of the epiregulin gene. Cancer Res. 63: 1743.
26. Lorick K.L., Jensen J.P., Fang S., Ong A.M., Hatakeyama S., and Weissman A.M. 1999. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. 96: 11364.
27. McDougall J.K. 1994. Immortalization and transformation of human cells by human papillomavirus. Curr. Top. Microbiol. Immunol. 186: 101.
28. Munger K., Basile J.R., Duensing S., Eichten A., Gonzalez S.L., Grace M., and Zacny V.L. 2001. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20: 7888.
29. Oh S.T., Kyo S., and Laimins L.A. 2001. Telomerase activation by human papillomavirus type 16 E6 protein: Induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. J. Virol. 75: 5559.
30. Sarin K.Y., Cheung P., Gilison D., Lee E., Tennen R.I., Wang E., Artandi M.K., Oro A.E., and Artandi S.E. 2005. Conditional telomerase induction causes proliferation of hair follicle stem cells (comment). Nature 436: 1048.
31. Shay J.W., Wright W.E., and Werbin H. 1991. Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta 1072: 1.
32. Smith L.L., Coller H.A., and Roberts J.M. 2003. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 5: 474.
33. Song Z., Krishna S., Thanos D., Strominger J.L., and Ono S.J. 1994. A novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional repressor. J. Exp. Med. 180: 1763.
34. Stewart S.A., Hahn W.C., O'Connor B.F., Banner E.N., Lundberg A.S., Modha P., Mizuno H., Brooks M.W., Fleming M., Zimonjic D.B., Popescu N.C., and Weinberg R.A. 2002. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism (comment). Proc. Natl. Acad. Sci. 99: 12606.
35. Takakura M., Kyo S., Sowa Y., Wang Z., Yatabe N., Maida Y., Tanaka M., and Inoue M. 2001. Telomerase activation by histone deacetylase inhibitor in normal cells. Nucleic Acids Res. 29: 3006.
36. van Steensel B., Smogorzewska A., and deLange T. 1998. TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401.
37. Vaziri H. and Benchimol S. 1998. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8: 279.
38. Veldman T., Horikawa I., Barrett J.C., and Schlegel R. 2001. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J. Virol. 75: 4467.
39. Veldman T., Liu X., Yuan H., and Schlegel R. 2003. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc. Natl. Acad. Sci. 100: 8211.
40. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide (comment). J. Pathol. 189: 12.
41. Wang J., Xie L.Y., Allan S., Beach D., and Hannon G.J. 1998. Myc activates telomerase. Genes Dev. 12: 1769.
42. Wu K.-J., Grandori C., Amacker M., Simon-Vermot N., Polack A., Lingner J., and Dalla-Favera R. 1999. Direct activation of TERT transcription by c-MYC. Nat. Genet. 21: 220.
43. Xu D., Popov N., Hou M., Wang Q., Bjorkholm M., Gruber A., Menkel A.R., and Henriksson M. 2001. Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc. Natl. Acad. Sci. 98: 3826.